AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28946522 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Therapy (MG)
Number of subjects: 113
Study 28946522 — intervention group
Group type: COMPARATOR
Intervention: Control Group (not explicitly mentioned)
Number of subjects: 113
Study 25663642 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily antioxidant therapy
Number of subjects: 78
Study 25663642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 25663642 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant therapy in chronic ITP
Number of subjects: 78
Study 25663642 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 78
Study 23494477 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential Outcomes Procedure (DOP) with three forms of consequences: (1) reinforcers given for correct choices ('+'), (2) reinforcers withdrawn for errors ('-'), (3) reinforcers given for correct choices and withdrawn for incorrect choices ('+/−')
Number of subjects: 0
Study 23494477 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential Outcomes Procedure (DOP) with different types of reinforcers (secondary and primary reinforcers in Experiment 1; primary reinforcers alone in Experiment 2)
Number of subjects: 0
Study 21292056 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) therapy consisting of eight 30- to 60-minute sessions across 4 weeks
Number of subjects: 50
Study 21292056 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control)
Number of subjects: 50
Study 19190819 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 46
Study 19190819 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 46
Study 17691365 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal Invasive Unilateral Technique (MIT)
Number of subjects: 20
Study 17691365 — intervention group
Group type: COMPARATOR
Intervention: Classical Midline Laminotomy technique (CML)
Number of subjects: 20
Study 15390011 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (titrated to 3,000 mg/day or lower maximal tolerated dose)
Number of subjects: 30
Study 15390011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11243949 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP), 0.5 mg/kg q6h for 3 days
Number of subjects: 36
Study 11243949 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP), 0.5 mg/kg q6h for 3 days, then tapered and terminated on the tenth day
Number of subjects: 36
Study 11243949 — intervention group
Group type: COMPARATOR
Intervention: Control group (3-day MP treatment)
Number of subjects: 36
Study 11243949 — intervention group
Group type: COMPARATOR
Intervention: Control group (10-day MP treatment)
Number of subjects: 36
Study 11243949 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 9683004 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g oral dosage of glucose
Number of subjects: 0
Study 9683004 — intervention group
Group type: COMPARATOR
Intervention: Saccharin
Number of subjects: 0
Study 9683004 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 0
Study 7516951 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha-2a
Number of subjects: 60
Study 7516951 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 60
Study 2509688 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene (non-absorbable suture)
Number of subjects: 100
Study 2509688 — intervention group
Group type: COMPARATOR
Intervention: PDS (absorbable suture)
Number of subjects: 100
Study 778998 — intervention group
Group type: EXPERIMENTAL
Intervention: Piribedil
Number of subjects: 17
Study 778998 — intervention group
Group type: EXPERIMENTAL
Intervention: Piribedil in association with L‐Dopa
Number of subjects: 17
Study 30954561 — intervention group
Group type: EXPERIMENTAL
Intervention: INT20 (sitting interrupted by 2 min of walking every 20th minute)
Number of subjects: 14
Study 30954561 — intervention group
Group type: EXPERIMENTAL
Intervention: INT60 (sitting interrupted by 6 min of walking every hour)
Number of subjects: 14
Study 30954561 — intervention group
Group type: EXPERIMENTAL
Intervention: INT120 (sitting interrupted by 12 min of walking every second hour)
Number of subjects: 14
Study 30954561 — intervention group
Group type: COMPARATOR
Intervention: SIT (uninterrupted sitting)
Number of subjects: 14
Study 27654143 — intervention group
Group type: EXPERIMENTAL
Intervention: Food advertisements
Number of subjects: 200
Study 27654143 — intervention group
Group type: COMPARATOR
Intervention: Toy advertisements
Number of subjects: 200
Study 25588568 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intra-aortic balloon pump
Number of subjects: 625
Study 24021325 — intervention group
Group type: EXPERIMENTAL
Intervention: Aegis with amorphous calcium phosphate sealant
Number of subjects: 110
Study 24021325 — intervention group
Group type: EXPERIMENTAL
Intervention: Delton illuminating sealant
Number of subjects: 110
Study 24021325 — intervention group
Group type: COMPARATOR
Intervention: Permanent maxillary 1st molars
Number of subjects: 110
Study 21737232 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe protein C deficiency
Number of subjects: 775
Study 21737232 — intervention group
Group type: COMPARATOR
Intervention: No severe protein C deficiency
Number of subjects: 775
Study 19453778 — intervention group
Group type: EXPERIMENTAL
Intervention: P-3051 (8% ciclopirox‐medicated nail lacquer)
Number of subjects: 467
Study 19453778 — intervention group
Group type: COMPARATOR
Intervention: Reference (market 8% ciclopirox nail lacquer)
Number of subjects: 467
Study 19453778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 467
Study 14688692 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-depleted terminal blood cardioplegia (LDTC)
Number of subjects: 54
Study 14688692 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 54
Study 11050493 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched 1064 nm Nd:YAG laser
Number of subjects: 40
Study 11050493 — intervention group
Group type: COMPARATOR
Intervention: Q-switched 755 nm alexandrite laser
Number of subjects: 40
Study 9412301 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire with numeracy scoring
Number of subjects: 500
Study 8399011 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wave Doppler studies of umbilical artery. Results immediately available to clinicians.
Number of subjects: 2289
Study 3776819 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase
Number of subjects: 52
Study 31185079 — intervention group
Group type: EXPERIMENTAL
Intervention: Capped specimens
Number of subjects: 290
Study 31185079 — intervention group
Group type: COMPARATOR
Intervention: Uncapped specimens
Number of subjects: 290
Study 31185079 — intervention group
Group type: EXPERIMENTAL
Intervention: LDH levels
Number of subjects: 290
Study 31185079 — intervention group
Group type: EXPERIMENTAL
Intervention: Free hemoglobin concentration
Number of subjects: 290
Study 29756308 — intervention group
Group type: EXPERIMENTAL
Intervention: App + Video Orientation (VG + App)
Number of subjects: 291
Study 29756308 — intervention group
Group type: EXPERIMENTAL
Intervention: App
Number of subjects: 291
Study 29756308 — intervention group
Group type: COMPARATOR
Intervention: Oral Group (OG)
Number of subjects: 291
Study 29756308 — intervention group
Group type: COMPARATOR
Intervention: Video Orientation (VG)
Number of subjects: 291
Study 29756308 — intervention group
Group type: EXPERIMENTAL
Intervention: All methods (OG, VG, OG + App, VG + App)
Number of subjects: 291
Study 26853484 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/d folate supplements
Number of subjects: 58
Study 24990642 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong responsibility condition (women)
Number of subjects: 161
Study 24990642 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong responsibility condition (men)
Number of subjects: 161
Study 24990642 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong SBA condition (women)
Number of subjects: 161
Study 24990642 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong SBA condition (men)
Number of subjects: 161
Study 22767210 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic repair (TAPP)
Number of subjects: 120
Study 22767210 — intervention group
Group type: COMPARATOR
Intervention: Open repair (mesh)
Number of subjects: 120
Study 22767210 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients under 65 years
Number of subjects: 120
Study 21226431 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Supreme (SLMA)
Number of subjects: 90
Study 21226431 — intervention group
Group type: COMPARATOR
Intervention: I-Gel
Number of subjects: 90
Study 18570896 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii treatment
Number of subjects: 40
Study 18570896 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 40
Study 18570896 — intervention group
Group type: COMPARATOR
Intervention: Control (patients with chronic idiopathic diarrhea)
Number of subjects: 40
Study 15949484 — intervention group
Group type: EXPERIMENTAL
Intervention: Elasticated support bandage
Number of subjects: 50
Study 15949484 — intervention group
Group type: COMPARATOR
Intervention: Plaster immobilisation
Number of subjects: 50
Study 12606903 — intervention group
Group type: EXPERIMENTAL
Intervention: Video system for initial training (n = 16)
Number of subjects: 36
Study 12606903 — intervention group
Group type: COMPARATOR
Intervention: Nonvideo system for initial training (n = 20)
Number of subjects: 36
Study 11251331 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of enoxaparin administered subcutaneously
Number of subjects: 24
Study 9081373 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical ultrasonography
Number of subjects: 50
Study 9081373 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound fine-needle aspiration biopsy (UGFAB)
Number of subjects: 50
Study 1855737 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg twice daily for 1 year)
Number of subjects: 13
Study 1855737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 6887078 — intervention group
Group type: EXPERIMENTAL
Intervention: formal EMG‐feedback training
Number of subjects: 18
Study 6887078 — intervention group
Group type: EXPERIMENTAL
Intervention: combined training of EMG‐feedback and progressive relaxation
Number of subjects: 18
Study 6887078 — intervention group
Group type: COMPARATOR
Intervention: waiting list
Number of subjects: 18
Study 31826368 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation (3.4 g) combined with muscle strengthening exercises
Number of subjects: 31
Study 31826368 — intervention group
Group type: COMPARATOR
Intervention: Control (1.2 g of starch)
Number of subjects: 31
Study 30202188 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-coalition intervention
Number of subjects: 0
Study 30202188 — intervention group
Group type: COMPARATOR
Intervention: Direct technical assistance for disseminating depression care
Number of subjects: 0
Study 26959879 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen (administered before skin incision and at the end of operation), n=30
Number of subjects: 60
Study 26959879 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 60
Study 26959879 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group C), n=30
Number of subjects: 60
Study 23764967 — intervention group
Group type: COMPARATOR
Intervention: Stratus TD‐OCT radial scan
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectralis HRA+OCT (radial)
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectralis HRA+OCT (7-line raster)
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectralis HRA+OCT (volumetric)
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrus HD‐OCT (5-line raster)
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrus HD‐OCT (volumetric)
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall detection of exudative disease activity
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraretinal cysts
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal fluid
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid in both locations
Number of subjects: 50
Study 23764967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrus volume
Number of subjects: 50
Study 22490315 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 40
Study 22490315 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 20368481 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster care
Number of subjects: 136
Study 20368481 — intervention group
Group type: COMPARATOR
Intervention: Institutional care as usual
Number of subjects: 136
Study 17394653 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment intervention designed to enhance treatment motivation, decrease crack use, and prepare for treatment entry.
Number of subjects: 443
Study 17394653 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 443
Study 17518402 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer assisted pedicle screw placement
Number of subjects: 10
Study 14620247 — intervention group
Group type: EXPERIMENTAL
Intervention: Random practice schedule, 102 trials over three days
Number of subjects: 72
Study 14620247 — intervention group
Group type: COMPARATOR
Intervention: Blocked practice schedule, 102 trials over three days
Number of subjects: 72
Study 10372878 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic macular photocoagulation (argon laser photocoagulation with 12 light spots)
Number of subjects: 0
Study 10372878 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study 8558187 — intervention group
Group type: EXPERIMENTAL
Intervention: VM26 120 mg/m2 on days 1, 3, and 5 with cisplatin 80 mg/m2 on day 1
Number of subjects: 225
Study 8558187 — intervention group
Group type: EXPERIMENTAL
Intervention: VM26 360 mg/m2 on day 1 with cisplatin 80 mg/m2 on day 1
Number of subjects: 225
Study 8558187 — intervention group
Group type: COMPARATOR
Intervention: VM26 120 mg/m2 on days 1, 3, and 5 without cisplatin
Number of subjects: 225
Study 8558187 — intervention group
Group type: COMPARATOR
Intervention: VM26 360 mg/m2 on day 1 without cisplatin
Number of subjects: 225
Study 1816217 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms thrice daily
Number of subjects: 90
Study 1816217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 7153940 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback training
Number of subjects: 4
Study 30294826 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health therapist intervention (OHTI)
Number of subjects: 359
Study 30294826 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention (NI)
Number of subjects: 359
Study 30294826 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention (PI)
Number of subjects: 359
Study 27562361 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing particulate-filtering respirators
Number of subjects: 24
Study 25557228 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (2 mg·kg(‐1))
Number of subjects: 28
Study 25557228 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 28
Study 24424704 — intervention group
Group type: EXPERIMENTAL
Intervention: ZST 1.75 mg
Number of subjects: 0
Study 24424704 — intervention group
Group type: EXPERIMENTAL
Intervention: ZST 3.5 mg
Number of subjects: 0
Study 24424704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24424704 — intervention group
Group type: EXPERIMENTAL
Intervention: ZST
Number of subjects: 0
Study 22947342 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention including measuring daily salt content, estimating 24-hour salt intake, and cooking classes with less salt
Number of subjects: 800
Study 22947342 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 800
Study 22947342 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 800
Study 19540517 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 27
Study 17047975 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone for 6 months
Number of subjects: 77
Study 17047975 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 77
Study 10878647 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status measured by anthropometry (Z-scores of height-for-age, weight-for-height, and weight-for-age)
Number of subjects: 28753
Study 10878647 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status measured by W/A and W/H
Number of subjects: 28753
Study 9023841 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 0
Study 9023841 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug combinations
Number of subjects: 0
Study 9023841 — intervention group
Group type: COMPARATOR
Intervention: Combination chemotherapy
Number of subjects: 0
Study 9023841 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study 1444723 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride
Number of subjects: 55
Study 3901821 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciramadol 60 mg
Number of subjects: 160
Study 3901821 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciramadol 30 mg
Number of subjects: 160
Study 3901821 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 10 mg
Number of subjects: 160
Study 3901821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 3901821 — intervention group
Group type: EXPERIMENTAL
Intervention: Active therapies (Ciramadol and Morphine)
Number of subjects: 160
Study 30430273 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate clinical information
Number of subjects: 115
Study 30430273 — intervention group
Group type: EXPERIMENTAL
Intervention: No clinical information
Number of subjects: 115
Study 30430273 — intervention group
Group type: EXPERIMENTAL
Intervention: Inaccurate clinical information
Number of subjects: 115
Study 30430273 — intervention group
Group type: COMPARATOR
Intervention: Inaccurate clinical information (no hernia on physical exam)
Number of subjects: 115
Study 30430273 — intervention group
Group type: COMPARATOR
Intervention: No clinical information (with hernia on physical exam)
Number of subjects: 115
Study 29317812 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY) 110/50 μg once daily for 4 weeks
Number of subjects: 88
Study 29317812 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium (18 μg) once daily for 4 weeks
Number of subjects: 88
Study 29317812 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY)
Number of subjects: 88
Study 24893912 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiocolchicine 4mg
Number of subjects: 25
Study 24893912 — intervention group
Group type: COMPARATOR
Intervention: Verapamil 5mg
Number of subjects: 25
Study 24662570 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (18 sessions, 3 times per week, 50% to 60% of VO2 peak, 25-40 minutes per session)
Number of subjects: 21
Study 24662570 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 21
Study 24662570 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining
Number of subjects: 21
Study 23177968 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural encoding of momentary evidence during decision making, measured through electrical brain signals, specifically parietal delta oscillations (1-3 Hz).
Number of subjects: 0
Study 23177968 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateralized beta-band power (10-30 Hz) overlying human motor cortex.
Number of subjects: 0
Study 20726884 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual stimulus presentation
Number of subjects: 0
Study 20726884 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate reach towards the target
Number of subjects: 0
Study 20726884 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual response in arm muscles
Number of subjects: 0
Study 18675765 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face medication consultation provided by a community pharmacy resident.
Number of subjects: 186
Study 18675765 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract).
Number of subjects: 186
Study 16438891 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast conserving therapy (BCT)
Number of subjects: 4461
Study 16438891 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 4461
Study 12494876 — intervention group
Group type: EXPERIMENTAL
Intervention: 50mg sildenafil + 5mg dihydro-ergotamine (DHE)
Number of subjects: 0
Study 10713873 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine 0.75%
Number of subjects: 45
Study 10713873 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine 1%
Number of subjects: 45
Study 10713873 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.5%
Number of subjects: 45
Study 7542929 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cancer screening service (service)
Number of subjects: 517
Study 7542929 — intervention group
Group type: COMPARATOR
Intervention: Education (leaflet on Pap smears)
Number of subjects: 517
Study 7542929 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 517
Study 2043493 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (10 mg/kg iv. loading dose + 7 hours continuous infusion) + lorazepam (2.5 mg x 4 po)
Number of subjects: 34
Study 2043493 — intervention group
Group type: COMPARATOR
Intervention: Low-dose metoclopramide (70 mg) + lorazepam (2.5 mg x 2 po) + dehydrobenzperidol (5 mg x 2 im)
Number of subjects: 34